We use cookies on our website to make it clear, useful and reliable.In order to achieve this and to provide certain personalised features we store a small amount of data about you. To learn more Click Here. By navigating from the front page to other sections of our website, you are consenting to information being stored.
Our latest news and events
A 30-year-old man has spoken about his pride in aiding the national fightback against COVID-19 by taking part in vaccine research in south London.
By NIHR Wellcome King's Clinical Research Facility at 26 Feb 2021A new paper funded by the NIHR Maudsley BRC, published today in Oxford Open Immunology, examines prior findings in the field of neuroimmunology that suggest potential treatment strategies for patients suffering long-term symptoms from COVID-19.
Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.
By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021King’s College London study assesses the potential impacts of COVID-19 nationwide lockdown on longer term depression, anxiety, and stress in gamblers in the UK.
By NIHR Maudsley BRC at 25 Jan 2021
Loneliness in adults aged 50 and over during the COVID-19 lockdown was linked to worsening depressive and other mental health symptoms, according to a large-scale online study.
By NIHR Maudsley BRC at 22 Jan 2021
The National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London. We are part of King’s Health Partners Academic Health Sciences Centre.
